
Matt Altman
Managing Partner
Matt joined Arlington in 2001 and is a Managing Partner at the Firm, where he focuses on Arlington’s Healthcare investments. Matt is a member of the Investment Committee and shares overall responsibility for all Firm management and investment activities. Prior to joining Arlington, Matt worked at Stonington Partners, a private equity fund established in 1994 by the principals of Merrill Lynch Capital Partners.
Matt is currently a director of Afton Scientific, AVS Bio, CBSET, Cordica Medical, Everest Clinical Research, Grand River Aseptic Manufacturing, and Millstone Medical Outsourcing.
Education
Duke University, B.A., summa cum laude, Economics
Stanford Graduate School of Business, MBA
Current investments
Select prior investments
- Riverpoint MedicalAcquired by Novanta (NASDAQ: NOVT)
- Endeavor RoboticsAcquired by FLIR Systems
- Advanced Health MediaAcquired by IQVIA (NYSE: IQV)
- Avalign TechnologiesAcquired by Linden Capital Partners
- MB AerospaceAcquired by Blackstone
- Micron TechnologiesAcquired by Catalent
- Cambridge Major LabsAcquired by American Capital Ltd.
- Chandler/MayAcquired by Lockheed Martin (NYSE: LMT)
- Consolidated Precision ProductsAcquired by Warburg Pincus